7.28
+0.06
+(0.83%)
At close: January 31 at 4:00:00 PM EST
7.25
-0.03
(-0.41%)
After hours: 7:56:27 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 33,154,573 | 67 |
Sales | 1,529,239 | 14 |
Net Shares Purchased (Sold) | 31,625,334 | 81 |
Total Insider Shares Held | 101.64k | -- |
% Net Shares Purchased (Sold) | -100.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
GUERIN MARK PATRICK Chief Financial Officer | -- | Direct | -- | Jun 10, 2024 |
DUKES IAIN D Officer and Director | -- | Indirect | -- | Apr 1, 2024 |
PAUZA CHARLES DAVID Officer | -- | Direct | -- | Apr 1, 2024 |
CAUTREELS WERNER C Chief Executive Officer | -- | Direct | -- | Apr 1, 2024 |
REDFIELD ROBERT Officer | -- | Direct | -- | Apr 1, 2024 |
SAVCHUK NIKOLAY Chief Operating Officer | -- | Indirect | -- | Apr 1, 2024 |
GUERIN MARK PATRICK Chief Operating Officer | -- | Direct | -- | Mar 13, 2024 |
FRUCHTMAN STEVEN M Chief Executive Officer | -- | Direct | -- | Mar 13, 2024 |
GUERIN MARK PATRICK Chief Operating Officer | -- | Direct | -- | Feb 7, 2024 |
FRUCHTMAN STEVEN M Chief Executive Officer | -- | Direct | -- | Feb 7, 2024 |
GUERIN MARK PATRICK Chief Operating Officer | -- | Direct | -- | Aug 2, 2023 |
FRUCHTMAN STEVEN M Chief Executive Officer | -- | Direct | -- | Aug 2, 2023 |
GUERIN MARK PATRICK Chief Operating Officer | -- | Direct | -- | Jun 12, 2023 |
GUERIN MARK PATRICK Chief Operating Officer | -- | Direct | -- | Feb 7, 2023 |
FRUCHTMAN STEVEN M Chief Executive Officer | -- | Direct | -- | Feb 7, 2023 |
GELDER MARK S Officer | -- | Direct | -- | Feb 7, 2023 |
Related Tickers
PLRZ Polyrizon Ltd.
1.1500
-12.88%
COEP Coeptis Therapeutics Holdings, Inc.
12.95
+1.09%
WINT Windtree Therapeutics, Inc.
0.1306
-2.54%
XCUR Exicure, Inc.
11.23
+3.89%
PRTG Portage Biotech Inc.
4.4100
-3.29%
SLRX Salarius Pharmaceuticals, Inc.
2.2400
+4.19%
APM Aptorum Group Limited
1.1600
-5.69%
TOVX Theriva Biologics, Inc.
1.2700
-0.78%
NEUP Neuphoria Therapeutics Inc.
5.30
-2.03%
KAPA Kairos Pharma, Ltd.
1.4300
-3.38%